T-Wave Test For ICD Need Has Different Role To Play For Healthier Patients
This article was originally published in The Gray Sheet
Executive Summary
Microvolt T-Wave Alternans (MTWA) testing should not be used alone to determine whether a relatively healthy heart attack survivor should get an implantable defibrillator (ICD), but it is still useful as a first-line risk stratifier for sudden cardiac death, according to a new study